Lactoferrin perturbs lipid rafts and requires integrity of Pma1p-lipid rafts association to exert its antifungal activity against Saccharomyces cerevisiae

Int J Biol Macromol. 2021 Feb 28:171:343-357. doi: 10.1016/j.ijbiomac.2020.12.224. Epub 2021 Jan 7.

Abstract

Lactoferrin (Lf) is a bioactive milk-derived protein with remarkable wide-spectrum antifungal activity. To deepen our understanding of the molecular mechanisms underlying Lf cytotoxicity, the role of plasma membrane ergosterol- and sphingolipid-rich lipid rafts and their association with the proton pump Pma1p was explored. Pma1p was previously identified as a Lf-binding protein. Results showed that bovine Lf (bLf) perturbs ergosterol-rich lipid rafts organization by inducing intracellular accumulation of ergosterol. Using yeast mutant strains lacking lipid rafts-associated proteins or enzymes involved in the synthesis of ergosterol and sphingolipids, we found that perturbations in the composition of these membrane domains increase resistance to bLf-induced yeast cell death. Also, when Pma1p-lipid rafts association is compromised in the Pma1-10 mutant and in the absence of the Pma1p-binding protein Ast1p, the bLf killing activity is impaired. Altogether, results showed that the perturbation of lipid rafts and the inhibition of both Pma1p and V-ATPase activities mediate the antifungal activity of bLf. Since it is suggested that the combination of conventional antifungals with lipid rafts-disrupting compounds is a powerful antifungal approach, our data will help to pave the way for the use of bLf alone or in combination for the treatment/eradication of clinically and agronomically relevant yeast pathogens/fungi.

Keywords: Lactoferrin; Lipid rafts; Pma1p; V-ATPase; Yeast cell death.

MeSH terms

  • Adenosine Triphosphate / metabolism
  • Antifungal Agents / pharmacology*
  • Drug Resistance, Fungal
  • Ergosterol / metabolism
  • Filipin
  • Green Fluorescent Proteins / analysis
  • Lactoferrin / pharmacology*
  • Membrane Microdomains / chemistry
  • Membrane Microdomains / drug effects*
  • Point Mutation
  • Proton-Translocating ATPases / biosynthesis
  • Proton-Translocating ATPases / genetics
  • Proton-Translocating ATPases / physiology*
  • Recombinant Fusion Proteins / analysis
  • Recombinant Fusion Proteins / biosynthesis
  • Saccharomyces cerevisiae / drug effects*
  • Saccharomyces cerevisiae / metabolism
  • Saccharomyces cerevisiae / ultrastructure
  • Saccharomyces cerevisiae Proteins / biosynthesis
  • Saccharomyces cerevisiae Proteins / genetics
  • Saccharomyces cerevisiae Proteins / physiology*
  • Vacuoles / drug effects
  • Vacuoles / enzymology
  • beta-Cyclodextrins / pharmacology

Substances

  • Antifungal Agents
  • Recombinant Fusion Proteins
  • Saccharomyces cerevisiae Proteins
  • beta-Cyclodextrins
  • methyl-beta-cyclodextrin
  • Green Fluorescent Proteins
  • Filipin
  • Adenosine Triphosphate
  • Lactoferrin
  • PMA1 protein, S cerevisiae
  • Proton-Translocating ATPases
  • Ergosterol